CRNX icon

Crinetics Pharmaceuticals

128 hedge funds and large institutions have $884M invested in Crinetics Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.05%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
20
Increased
59
Reduced
28
Closed
13
Calls
$472K
Puts
$2K
Net Calls
+$470K
Net Calls Change
+$447K
Name Holding Trade Value Shares
Change
Shares
Change %
AF
126
Allworth Financial
California
$1.61K +$1.61K +100 New
NA
127
NewEdge Advisors
Louisiana
$964
VFA
128
Values First Advisors
Tennessee
$7
DTC
129
Deep Track Capital
Connecticut
-$19.2M -1,048,829 Closed
SCM
130
Silverarc Capital Management
Massachusetts
-$2.8M -152,747 Closed
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
-$2.74M -147,000 Closed
Victory Capital Management
132
Victory Capital Management
Texas
-$1.22M -66,428 Closed
Renaissance Technologies
133
Renaissance Technologies
New York
-$1.16M -63,100 Closed
D.E. Shaw & Co
134
D.E. Shaw & Co
New York
-$575K -31,417 Closed
PI
135
Putnam Investments
Massachusetts
-$427K -23,338 Closed
SMH
136
Sanders Morris Harris
Texas
-$340K -18,600 Closed
ProShare Advisors
137
ProShare Advisors
Maryland
-$205K -11,222 Closed
PVH
138
Psagot Value Holdings
Israel
-$46K -2,500 Closed
HNWAG
139
High Net Worth Advisory Group
Florida
-$27.5K -1,500 Closed
Rockefeller Capital Management
140
Rockefeller Capital Management
New York
-$18K -1,000 Closed
Balyasny Asset Management
141
Balyasny Asset Management
Illinois
-$13.6K -744 Closed